Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -139.81%-38.37M | ---- | -123.80%-16M | ---- | 704.72%67.22M | ---- | 268.59%8.35M | ---- | -142.64%-4.95M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | 1.68%23.62M | ---- | 243.43%23.23M | ---- | --6.76M | ---- | ---- | ---- | 1,546.98%4.39M |
| Impairment and provisions: | ---- | -670.89%-217.93K | ---- | -70.68%38.17K | ---- | 192.39%130.21K | ---- | -244.94%-140.94K | ---- | -91.78%97.24K |
| -Impairmen of inventory (reversal) | ---- | -421.55%-541.49K | ---- | -218.67%-103.82K | ---- | 155.92%87.49K | ---- | -1,542.56%-156.46K | ---- | -99.07%10.85K |
| -Impairment of trade receivables (reversal) | ---- | 127.87%323.57K | ---- | 232.38%142K | ---- | 175.26%42.72K | ---- | -82.04%15.52K | ---- | 332.58%86.39K |
| Revaluation surplus: | ---- | 23,322.05%9.82M | ---- | 97.23%-42.28K | ---- | 87.06%-1.53M | ---- | -490.60%-11.79M | ---- | -14.46%3.02M |
| -Other fair value changes | ---- | 23,322.05%9.82M | ---- | 97.23%-42.28K | ---- | 87.06%-1.53M | ---- | -490.60%-11.79M | ---- | -14.46%3.02M |
| Asset sale loss (gain): | ---- | 100.01%1.22K | ---- | 86.87%-11.22M | ---- | -7,958.27%-85.44M | ---- | 81.26%-1.06M | ---- | 75.10%-5.66M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 86.81%-11.35M | ---- | -9,600.49%-85.99M | ---- | 85.06%-886.48K | ---- | 73.94%-5.94M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -99.02%1.22K | ---- | -77.39%125.28K | ---- | 2,824.09%554K | ---- | -61.16%18.95K | ---- | -8.98%48.78K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -184.61%-192.73K | ---- | --227.79K |
| Depreciation and amortization: | ---- | -6.37%5.87M | ---- | -57.44%6.27M | ---- | 56.07%14.73M | ---- | 166.92%9.44M | ---- | 148.26%3.54M |
| -Amortization of intangible assets | ---- | -7.72%3.68M | ---- | -53.16%3.99M | ---- | 90.64%8.51M | ---- | 635.02%4.47M | ---- | 31.23%607.65K |
| Financial expense | ---- | ---- | ---- | ---- | ---- | 18.73%1.2M | ---- | 427.14%1.01M | ---- | ---308.79K |
| Special items | ---- | -129.02%-450.01K | ---- | ---196.49K | ---- | ---- | ---- | -194.78%-1.45M | ---- | 381.05%1.53M |
| Operating profit before the change of operating capital | ---- | -86.63%278.07K | ---- | -32.46%2.08M | ---- | -29.35%3.08M | ---- | 163.83%4.36M | ---- | 131.51%1.65M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 154.17%1.23M | ---- | 1.07%482.43K | ---- | 300.10%477.34K | ---- | -105.70%-238.56K | ---- | 171.97%4.19M |
| Accounts receivable (increase)decrease | ---- | 682.15%2.16M | ---- | -97.97%276.59K | ---- | 8.91%13.66M | ---- | 151.62%12.54M | ---- | -6,886.25%-24.29M |
| Accounts payable increase (decrease) | ---- | 165.57%799.65K | ---- | -106.98%-1.22M | ---- | 13,855.50%17.48M | ---- | 98.82%-127.08K | ---- | -152.32%-10.78M |
| Special items for working capital changes | ---- | 52.98%-4.87M | ---- | -54.41%-10.37M | ---- | -12.57%-6.71M | ---- | -125.60%-5.96M | ---- | 1.65%23.29M |
| Cash from business operations | -14.37%-3.27M | 95.35%-406.52K | 65.42%-2.86M | -131.25%-8.75M | -151.32%-8.26M | 164.71%27.98M | -0.95%16.1M | 277.89%10.57M | 1,009.46%16.25M | -118.51%-5.94M |
| Other taxs | ---- | 99.78%-7.75K | 99.86%-4.81K | -3,853.72%-3.46M | -5,826.95%-3.49M | -51.53%92.1K | 432.67%60.93K | 149.75%190.01K | -160.35%-18.32K | -725.62%-381.92K |
| Interest paid - operating | 8.62%-32.07K | 82.98%-58.86K | 86.02%-35.09K | 74.05%-345.8K | 64.75%-251.01K | -7.56%-1.33M | -7.36%-712.01K | -568.68%-1.24M | -1,626.86%-663.2K | -37.93%-185.26K |
| Net cash from operations | -13.90%-3.3M | 96.23%-473.12K | 75.86%-2.9M | -146.92%-12.55M | -177.70%-12M | 180.84%26.74M | -0.79%15.45M | 246.28%9.52M | 967.42%15.57M | -120.39%-6.51M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 12.61%245.83K | -2.53%508.87K | 1.94%218.3K | 394.23%522.07K | 375.91%214.16K | -61.76%105.63K | -71.83%45K | -47.09%276.23K | -46.35%159.75K | -28.48%522.1K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 646.34%27.51M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---379.95K | ---- | ---- | -88.43%519.27K |
| Sale of fixed assets | -95.24%213 | -99.24%4.6K | -99.26%4.48K | -77.35%608.28K | --605.3K | 70,762.22%2.69M | ---- | -71.76%3.79K | -75.61%3.77K | 309.58%13.42K |
| Purchase of fixed assets | -645.43%-527.4K | 36.58%-285.19K | 57.47%-70.75K | 89.51%-449.68K | 85.11%-166.35K | 31.96%-4.29M | -10.35%-1.12M | 29.37%-6.3M | 75.28%-1.01M | -188.42%-8.92M |
| Purchase of intangible assets | ---- | 35.11%-4.55K | ---- | 99.65%-7.01K | 88.78%-4.65K | 83.71%-1.99M | 99.38%-41.49K | 62.78%-12.23M | 51.83%-6.69M | -3,153.65%-32.87M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | --16.09M | ---- | ---- | ---- | -605.56%-28.1M |
| Recovery of cash from investments | --228.06K | -97.78%43.13K | ---- | --1.94M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 44.54%-8.04M | -108.53%-1.55M | -887.87%-14.49M |
| Other items in the investment business | --417 | --106K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -134.78%-52.88K | -85.75%372.85K | -76.56%152.03K | -79.24%2.62M | 143.41%648.45K | 147.94%12.61M | 83.55%-1.49M | 52.89%-26.29M | 50.85%-9.08M | -495.84%-55.81M |
| Net cash before financing | -22.13%-3.35M | 98.99%-100.27K | 75.82%-2.74M | -125.24%-9.93M | -181.37%-11.35M | 334.65%39.35M | 115.00%13.95M | 73.09%-16.77M | 132.02%6.49M | -376.23%-62.32M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | -55.88%6.62M | --6.6M | -65.24%15.01M | ---- | 3,498.94%43.19M |
| Refund | ---- | ---- | ---- | -10.05%-16.71M | -312.83%-12.38M | 40.23%-15.19M | 63.90%-3M | -262.56%-25.41M | ---8.31M | -7.15%-7.01M |
| Issuing shares | ---- | ---- | ---- | 15,045.29%614.6K | --138.77K | -97.21%4.06K | ---- | -23.43%145.21K | -82.63%9.6K | 141.75%189.64K |
| Dividends paid - financing | -0.00%-416.58K | -1.83%-416.58K | -1.83%-416.58K | -0.22%-409.1K | -0.22%-409.1K | 0.83%-408.21K | 0.83%-408.21K | -0.84%-411.61K | -0.84%-411.61K | -0.68%-408.16K |
| Net cash from financing operations | -4.27%-930.4K | 92.05%-1.36M | 93.12%-892.31K | -76.73%-17.08M | -577.17%-12.97M | 14.75%-9.67M | 130.08%2.72M | -131.78%-11.34M | -251.85%-9.03M | 698.36%35.68M |
| Effect of rate | 91.26%-8K | 94.18%-37.93K | 90.81%-91.61K | -162.00%-651.21K | -13.96%-996.58K | -158.61%-248.55K | -363.13%-874.51K | -80.96%424.06K | 148.12%332.35K | 437.45%2.23M |
| Net Cash | -17.75%-4.28M | 94.60%-1.46M | 85.05%-3.64M | -191.01%-27.01M | -245.89%-24.32M | 205.60%29.68M | 755.26%16.67M | -5.48%-28.11M | 82.24%-2.54M | -260.53%-26.65M |
| Begining period cash | -7.27%19.07M | -57.36%20.57M | -57.36%20.57M | 156.57%48.23M | 156.57%48.23M | -59.56%18.8M | -59.56%18.8M | -34.44%46.48M | -34.44%46.48M | 29.00%70.9M |
| Cash at the end | -12.22%14.78M | -7.27%19.07M | -26.51%16.84M | -57.36%20.57M | -33.77%22.91M | 156.57%48.23M | -21.85%34.6M | -59.56%18.8M | -20.79%44.27M | -34.44%46.48M |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.